Neurology

As per DelveInsight, the Dravet syndrome market size was estimated to be USD 79.1 Million in 2017, which is expected to increase at a significant CAGR during the study period (2017–2030) owing to rich Dravet syndrome pipeline, increasing incidence, and heightened R&D. Dravet Syndrome, earlier known as severe myoclonic epilepsy of infancy (SMEI), is rare, early-life epilepsy. It manifests as seizures, neurodevelopmental delays, which with age, progresses to neurologic disability. Dravet syndrome manifestations usually start to become more evident in the very initial months/years of life. In early childhood, febrile seizures occur, accompanied with non-febrile s...